| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
|
J Am Dent Assoc, Vol 137, No 8, 1144-1150.
© 2006 American Dental Association |  |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ASSOCIATION REPORT |
Expert panel recommendations
Background. In light of the uncertainty surrounding the incidence of bisphosphonate-associated osteonecrosis of the jaw (BON) and concomitant risk factors, dentists have questioned how to manage the care of patients receiving oral bisphosphonate therapy. Expert panelists were selected by the American Dental Association Council on Scientific Affairs on the basis of their expertise in the relevant subject matter and on their respective dental or medical specialties, and the panel was tasked with developing guidance for dentists treating these patients.
Methods. There are no data from clinical trials evaluating dental management of the care of patients receiving oral bisphosphonate therapy and, therefore, these recommendations are based on a thorough review of the available literature relating to bisphosphonate use and osteonecrosis of the jaw. After reviewing the literature, the panel developed these recommendations based on their expert opinion.
Results. These panel recommendations focus on conservative surgical procedures, proper sterile technique, appropriate use of oral disinfectants and the principles of effective antibiotic therapy.
Conclusions. The recommendations are a resource for dentists to use in their practice, in addition to the dentist’s own professional judgment, the information available in the dental and medical literature, and information from the patient’s treating physician. The recommendations must be balanced with the practitioner’s professional judgment and the individual patient’s preferences and needs.
This article has been cited by other articles:
|
|
 |
|
  G. FAVIA, G. P. PILOLLI, and E. MAIORANO Osteonecrosis of the Jaw Correlated to Bisphosphonate Therapy in Non-oncologic Patients: Clinicopathological Features of 24 Patients J Rheumatol, December 1, 2009; 36(12): 2780 - 2787. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Beslija, J. Bonneterre, H. J. Burstein, V. Cocquyt, M. Gnant, V. Heinemann, J. Jassem, W. J. Kostler, M. Krainer, S. Menard, et al. Third consensus on medical treatment of metastatic breast cancer Ann. Onc., November 1, 2009; 20(11): 1771 - 1785. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. A. BUENCAMINO, L. PALOMO, and H. L. THACKER How menopause affects oral health, and what we can do about it Cleveland Clinic Journal of Medicine, August 1, 2009; 76(8): 467 - 475. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Almazrooa and S.-B. Woo Bisphosphonate and Nonbisphosphonate-Associated Osteonecrosis of the Jaw: A Review J Am Dent Assoc, July 1, 2009; 140(7): 864 - 875. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. CAMPISI, S. FEDELE, G. COLELLA, A. L. CASTO, and V. FUSCO To the Editor J Rheumatol, February 1, 2009; 36(2): 451 - 452. [Full Text] [PDF]
|
|
|
|
|
|
P. P. Sedghizadeh, K. Stanley, M. Caligiuri, S. Hofkes, B. Lowry, and C. F. Shuler Oral bisphosphonate use and the prevalence of osteonecrosis of the jaw: An institutional inquiry J Am Dent Assoc, January 1, 2009; 140(1): 61 - 66. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Dimopoulos, E. Kastritis, C. Bamia, I. Melakopoulos, D. Gika, M. Roussou, M. Migkou, E. Eleftherakis-Papaiakovou, D. Christoulas, E. Terpos, et al. Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid Ann. Onc., January 1, 2009; 20(1): 117 - 120. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Badros, E. Terpos, E. Katodritou, O. Goloubeva, E. Kastritis, E. Verrou, K. Zervas, M. R. Baer, T. Meiller, and M. A. Dimopoulos Natural History of Osteonecrosis of the Jaw in Patients With Multiple Myeloma J. Clin. Oncol., December 20, 2008; 26(36): 5904 - 5909. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. CAREY and L. PALOMO Bisphosphonates and osteonecrosis of the jaw: Innocent association or significant risk? Cleveland Clinic Journal of Medicine, December 1, 2008; 75(12): 871 - 879. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. Edwards, J. W. Hellstein, P. L. Jacobsen, S. Kaltman, A. Mariotti, C. A. Migliorati, and for the American Dental Association Council on Sci Updated recommendations for managing the care of patients receiving oral bisphosphonate therapy: An advisory statement from the American Dental Association Council on Scientific Affairs J Am Dent Assoc, December 1, 2008; 139(12): 1674 - 1677. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Mariotti Bisphosphonates and Osteonecrosis of the Jaws J Dent Educ., August 1, 2008; 72(8): 919 - 929. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. L. Estilo, C. H. Van Poznak, T. Wiliams, G. C. Bohle, P. T. Lwin, Q. Zhou, E. R. Riedel, D. L. Carlson, H. Schoder, A. Farooki, et al. Osteonecrosis of the Maxilla and Mandible in Patients with Advanced Cancer Treated with Bisphosphonate Therapy Oncologist, August 1, 2008; 13(8): 911 - 920. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. Edwards and C. A. Migliorati Osteoporosis and Its Implications for Dental Patients J Am Dent Assoc, May 1, 2008; 139(5): 545 - 552. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. T. Grbic, R. Landesberg, S.-Q. Lin, P. Mesenbrink, I. R. Reid, P.-C. Leung, N. Casas, C. P. Recknor, Y. Hua, P. D. Delmas, et al. Incidence of Osteonecrosis of the Jaw in Women With Postmenopausal Osteoporosis in the Health Outcomes and Reduced Incidence With Zoledronic Acid Once Yearly Pivotal Fracture Trial J Am Dent Assoc, January 1, 2008; 139(1): 32 - 40. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Siegel, C. A. Migliorati, I. Velez, and M. Forrest Exposed bone in the palate J Am Dent Assoc, October 1, 2007; 138(10): 1341 - 1343. [Full Text] [PDF]
|
|
|
|
 |
|
 N. G. Shenker and A. S. M. Jawad Bisphosphonates and osteonecrosis of the jaw Rheumatology, July 1, 2007; 46(7): 1049 - 1051. [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Mayes Review of Postmenopausal Osteoporosis Pharmacotherapy Nutr Clin Pract, June 1, 2007; 22(3): 276 - 285. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Compston Treatments for Osteoporosis -- Looking beyond the HORIZON N. Engl. J. Med., May 3, 2007; 356(18): 1878 - 1880. [Full Text] [PDF]
|
|
|
|
|
|
V. Kumar, B. Pass, S. A. Guttenberg, J. Ludlow, R. W. Emery, D. A. Tyndall, and R. J. Padilla Bisphosphonate-related osteonecrosis of the jaws: A report of three cases demonstrating variability in outcomes and morbidity J Am Dent Assoc, May 1, 2007; 138(5): 602 - 609. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Glick Informed consent: A delicate balance. J Am Dent Assoc, August 1, 2006; 137(8): 1060 - 1062. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
